newsfilter
← Latest News
Business Wire·

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results

Nuzefatide pevedotin granted FDA Orphan Drug Designation for the treatment of pancreatic cancer; further updates expected in 2027 Initiation of the first company-sponsored radioligand clinical trial for BT1702, an